Today: 13 June 2026
Singapore Airlines stock slips as oil climbs on Iran fears; Feb 24 update looms
13 January 2026
1 min read

Singapore Airlines stock slips as oil climbs on Iran fears; Feb 24 update looms

Singapore, Jan 13, 2026, 15:33 SGT — Regular session

  • Singapore Airlines shares slipped 0.5% to S$6.40 in afternoon trading
  • Oil prices climb further, spotlighting rising airline fuel expenses
  • Investors are focused on SIA’s business update for the third quarter, due February 24

Shares of Singapore Airlines Ltd fell 0.5% to S$6.40 by Tuesday afternoon, pressured by rising oil prices weighing on airline margins. The stock started the day at S$6.45 and hit a low near S$6.38, after briefly touching S$6.45 earlier in the session.

Fuel remains the key swing factor traders watch closely. Jet fuel typically follows crude prices but with a delay. Airlines often find it tough to immediately pass sharp cost increases onto fares, particularly on highly competitive routes.

Singapore Airlines is set to release its third-quarter business update on Feb. 24, per its investor relations calendar.

Brent crude edged up 0.3% to $64.09 a barrel in Asian trading, staying close to a two-month peak. Concerns over supply disruptions in Iran outweighed hopes for increased output from Venezuela. ING’s commodities strategists highlighted growing protests in Iran, and Barclays estimated that the unrest has pushed the geopolitical risk premium by around $3-$4 a barrel.

Singapore Airlines’ latest results came with a familiar caution: rising costs and pressure on yields. In November, the carrier disclosed a steep drop in first-half profit, hit by losses from its associate Air India, increased expenses, and tougher competition that weighed on passenger yields, according to the company and Reuters.

In airline jargon, yield refers to the revenue generated per passenger per kilometre flown. It usually drops when airlines boost capacity or lower fares to fill seats, even if planes are running full.

The carrier declared an interim dividend of 5 Singapore cents per share alongside a special interim dividend of 3 cents for H1 FY2025/26. Payment occurred on Dec. 23, following an ex-dividend date on Dec. 5, according to its dividend information page.

There’s a clear downside risk. If crude prices continue to rise alongside jet fuel, cost pressures could intensify just as airlines battle tougher competition for passengers. On top of that, a bigger-than-anticipated hit from Air India would only add fuel to the fire.

Stock Market Today

  • Axon Enterprise Stock Review: Valuation and Recent Price Volatility
    June 13, 2026, 1:39 AM EDT. Axon Enterprise (AXON) closed at $441.73 amid share price volatility, declining 1.0% in 1 day and 9.13% over 7 days, despite a 30-day gain of 17.23%. The 1-year shareholder return stands at a 43.41% decline. Analysts suggest a fair value estimate of $606.83, indicating the stock may be undervalued by 27.2%. Axon's shift from hardware to a software and data platform for public safety underpins growth potential. However, the stock trades at a rich price-to-sales (P/S) ratio of 11.9x, compared to the aerospace/defense industry average of 5.6x, reflecting valuation risks if market sentiment shifts or budget constraints arise. Investors should weigh Axon's long-term platform economics against potential headwinds in public sector spending and competitive pressures.

Latest articles

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

13 June 2026
NCR Voyix soared 10.25% to $7.85, far outpacing the market, as investors focus on the company’s 2026 cash-flow and earnings targets; the next key catalyst is the Q2 2026 earnings update, with stock valuation appearing low if management delivers on margin and cash-flow goals, but risks remain with declining reported revenue and high debt.
Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal
Previous Story

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread
Next Story

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread

Go toTop